Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Aligos Therapeutics Enters into Exclusive License Deal with Xiamen Amoytop Biotech Co., Ltd. to Develop and Commercialize Pevifoscorvir Sodium in Greater China for Chronic Hepatitis B Virus Infection
-
SnapLogic Announces AI Gateway and Trusted Agent Identity to Power the Era of Digital Labor
-
Clear Street Expands European Market Access with MiFID II License in the Netherlands
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Anywhere Real Estate Inc. Investors Who Received Compass, Inc. (COMP) Shares in Connection with Compass’s Acquisition of Anywhere in Jan
-
MEXC Unveils Largest-Ever 0-Fee Festival, Empowering Users to Unlock Infinite Opportunities
-
Erayak Power Solution Group Inc. Announces 1-for-10 Reverse Stock Split Effective April 20, 2026
-
Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026
-
Global Net Lease, Inc. Announces Release Date for First Quarter 2026 Results
-
SITA research finds aviation’s record technology investment hinges on one thing: data coordination
-
From Pandas to AI: Chengdu Hosts the China Internet Audio & Video Convention for the 13th Consecutive Year, Building an Eastern Hub for Global Audio & Video Collaboration
-
From Pandas to AI: Chengdu Hosts the China Internet Audio & Video Convention for the 13th Consecutive Year, Building an Eastern Hub for Global Audio & Video Collaboration
-
Insurance litigation doubles since introduction of Insurance Act 2015, according to analysis by insurance expert Mactavish
-
Kering forms a strategic partnership with ICCF around flagship brand ICICLE, and acquires a minority stake
-
Form 8.5 (EPT/RI)- Alternative Income REIT Plc
-
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med SKAKO aktier
-
K Wave Media Reports Strong Momentum Across Film and Drama IP Portfolio, Highlighting Breakout Box Office Success and Cannes Recognition
-
Form 8.5 (EPT/RI) - CAB Payments Holdings Plc
-
Form 8.5 (EPT/RI) - PPHE Hotel Group Limited
-
CREA Downgrades Resale Housing Market Forecast
-
Canadian Home Sales Activity Little Changed in March
-
Report: Oil Shock Sends Freight Costs to COVID-Era Levels
-
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
-
Focus Markets Unveils Strategic Growth Transformation; Appoints Industry Veteran Martin Doepke as CEO
-
Form 8.5 (EPT/RI)- Gamma Communications Plc
-
Correction: Results 1st quarter 2026 | Portfolio expansion delivers expected performance
-
Trans-Caspian route of China Railway Express from Xi'an sees 150 pct trip surge in Q1
-
Trans-Caspian route of China Railway Express from Xi'an sees 150 pct trip surge in Q1
-
Auctions/tap sales of mortgage covered bonds (SDRO’s) for the refinancing of RD Cibor6®, RD Cibor6® Green, FlexKort® and RD Euribor3®
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GAMMA COMMUNICATIONS PLC - Ordinary Shares
-
Wood Mackenzie: Six-country international shale priority list for energy security as Middle East conflict drives supply diversification
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
Refresco Europe Partners with ISN® to Help Advance Contractor Oversight Across European Operations
-
Questex’s StreamTV Europe Debuted in Lisbon, Uniting Streaming Leaders Across Content, Platforms, Advertising, and Technology
-
Energy market defined by “striking contradiction”, according to latest Willis Energy Market Review
-
Share Buyback Transaction Details April 9 – April 15, 2026
-
Alethio Therapeutics Unveils ATX‑011, a Breakthrough, Mutation‑Agnostic Antibody for Treating Essential Thrombocythemia – a c.$2B Market, and Strengthens Leadership to Accelerate Path to IND
-
Form 8.3 - [IDOX PLC - 15 04 2026] - (CGWL)
-
Freya Biosciences announces positive Phase 1 first-in-human data with FB301 for IVF-related embryo implantation failure
-
Crypto News: AlphaPepe $860k Raised While Bitcoin Price Prediction from Standard Chartered Maintains $150,000 Target for 2026
-
Team UK announced for global ‘Skills Olympics’ in Shanghai
-
Kleene.ai Launches KAI Assistant — A Native AI Interface for Its Data and Analytics Platform
-
Notification of major shareholding
-
CancerVax to Target Colorectal Cancer Following Recent Biodistribution Breakthroughs
-
STORM Therapeutics Secures $56 Million Series C Financing and Doses First Patient in Phase 2 Sarcoma Trial of STC‑15
-
Two-thirds of organizations rate physical AI as a high priority for the next three to five years
-
Michelin: Disclosure of trading in own shares - April 16th, 2026
-
CSG introduces counter-drone ammunition enabling soldiers to neutralize UAV threats with standard rifles
-
TME Pharma Announces Publication of NOX-A12 “Triple Therapy” Phase 1/2 Expansion Arm A Findings from GLORIA trial in Nature Communications
-
Nokia and Cinia partner to secure Finland’s critical infrastructure with advanced DDoS protection
-
Q3 Trading Statement 2025/26: Bang & Olufsen generated 1% revenue growth in local currencies for the quarter

